It is conceivable that one of the possible escape mechanisms triggered by neoplastic cells to overcome the inhibition of a molecule acting as main driver, as HER2 in BC, is the recruitment and/or hyperactivation of a cognate receptor. Here, ERBB2 is linked to breast cancer.